aluates Reports

$ 0.0

Automative

Global Mammalian Cell Line Development Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-0Y18827

BUY CHAPTERS

Global Mammalian Cell Line Development Market Research Report 2024

Code: QYRE-Auto-0Y18827

Report

October 2024

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

AGC Biologics

Sigma-aldrich

Fraunhofer

Cytena

GTP Bioways

KBI Biopharma

Lonza

Abzena

FUJIFILM Diosynth Biotechnologies

HERA

Wuxi Biologics

Danaher

Northway Biotech

Sartorius

EirGenix Inc.

FyoniBio GmbH

Creative Biogene

Rodon Biologics

Tanvex

Menarini Biotech

Mammalian Cell Line Development Market Size

The global Mammalian Cell Line Development market was valued at US$ 234 million in 2023 and is anticipated to reach US$ 441 million by 2030, witnessing a CAGR of 9.5% during the forecast period 2024-2030.

Mammalian Cell Line Development Market

Mammalian cell line development refers to the process of creating and optimizing cell lines derived from mammalian species, such as humans, mice, or monkeys, for use in research, biopharmaceutical production, and other applications. This involves selecting a suitable cell type, establishing a stable cell line, and optimizing growth conditions to ensure high productivity and consistency. Mammalian cell lines are commonly used in the production of recombinant proteins, monoclonal antibodies, and vaccines, as they closely mimic the physiology and function of human cells, making them valuable tools for studying disease mechanisms and developing new therapies. The development of mammalian cell lines is a crucial step in biotechnology and biomedical research, enabling the production of complex biological molecules and advancing our understanding of human health and disease.

North American market for Mammalian Cell Line Development is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Mammalian Cell Line Development is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Mammalian Cell Line Development in Biopharmaceutical Production is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Mammalian Cell Line Development include Thermo Fisher Scientific, AGC Biologics, Sigma-Aldrich, Fraunhofer, Cytena, GTP Bioways, KBI Biopharma, Lonza, Abzena, FUJIFILM Diosynth Biotechnologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Mammalian Cell Line Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian Cell Line Development.

The Mammalian Cell Line Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mammalian Cell Line Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mammalian Cell Line Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Mammalian Cell Line Development Market Report

Report Metric	Details
Report Name	Mammalian Cell Line Development Market
Accounted market size in 2023	US$ 234 million
Forecasted market size in 2030	US$ 441 million
CAGR	9.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	CHO (Chinese Hamster Ovary) Cells HEK (Human Embryonic Kidney) Cells NS0 (Mouse Myeloma) Cells BHK (Baby Hamster Kidney) Cells Others
Segment by Application	Biopharmaceutical Production Drug Discovery and Development Toxicity Testing Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, AGC Biologics, Sigma-Aldrich, Fraunhofer, Cytena, GTP Bioways, KBI Biopharma, Lonza, Abzena, FUJIFILM Diosynth Biotechnologies, Hera, WuXi Biologics, Danaher, Northway Biotech, Sartorius, EirGenix, Tanvex, Menarini Biotech, FyoniBio, Creative Biogene, Rodon Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mammalian Cell Line Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Mammalian Cell Line Development Market growing?

Ans: The Mammalian Cell Line Development Market witnessing a CAGR of 9.5% during the forecast period 2024-2030.

What is the Mammalian Cell Line Development Market size in 2030?

Ans: The Mammalian Cell Line Development Market size in 2030 will be US$ 441 million.

Who are the main players in the Mammalian Cell Line Development Market report?

Ans: The main players in the Mammalian Cell Line Development Market are Thermo Fisher Scientific, AGC Biologics, Sigma-Aldrich, Fraunhofer, Cytena, GTP Bioways, KBI Biopharma, Lonza, Abzena, FUJIFILM Diosynth Biotechnologies, Hera, WuXi Biologics, Danaher, Northway Biotech, Sartorius, EirGenix, Tanvex, Menarini Biotech, FyoniBio, Creative Biogene, Rodon Biologics

What are the Application segmentation covered in the Mammalian Cell Line Development Market report?

Ans: The Applications covered in the Mammalian Cell Line Development Market report are Biopharmaceutical Production, Drug Discovery and Development, Toxicity Testing, Others

What are the Type segmentation covered in the Mammalian Cell Line Development Market report?

Ans: The Types covered in the Mammalian Cell Line Development Market report are CHO (Chinese Hamster Ovary) Cells, HEK (Human Embryonic Kidney) Cells, NS0 (Mouse Myeloma) Cells, BHK (Baby Hamster Kidney) Cells, Others

Recommended Reports

Cell Line Development

Cell Culture Systems

Cell-based Technologies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mammalian Cell Line Development Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CHO (Chinese Hamster Ovary) Cells

1.2.3 HEK (Human Embryonic Kidney) Cells

1.2.4 NS0 (Mouse Myeloma) Cells

1.2.5 BHK (Baby Hamster Kidney) Cells

1.2.6 Others

1.3 Market by Application

1.3.1 Global Mammalian Cell Line Development Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Biopharmaceutical Production

1.3.3 Drug Discovery and Development

1.3.4 Toxicity Testing

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mammalian Cell Line Development Market Perspective (2019-2030)

2.2 Global Mammalian Cell Line Development Growth Trends by Region

2.2.1 Global Mammalian Cell Line Development Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Mammalian Cell Line Development Historic Market Size by Region (2019-2024)

2.2.3 Mammalian Cell Line Development Forecasted Market Size by Region (2025-2030)

2.3 Mammalian Cell Line Development Market Dynamics

2.3.1 Mammalian Cell Line Development Industry Trends

2.3.2 Mammalian Cell Line Development Market Drivers

2.3.3 Mammalian Cell Line Development Market Challenges

2.3.4 Mammalian Cell Line Development Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Mammalian Cell Line Development Players by Revenue

3.1.1 Global Top Mammalian Cell Line Development Players by Revenue (2019-2024)

3.1.2 Global Mammalian Cell Line Development Revenue Market Share by Players (2019-2024)

3.2 Global Mammalian Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Mammalian Cell Line Development Revenue

3.4 Global Mammalian Cell Line Development Market Concentration Ratio

3.4.1 Global Mammalian Cell Line Development Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Line Development Revenue in 2023

3.5 Global Key Players of Mammalian Cell Line Development Head office and Area Served

3.6 Global Key Players of Mammalian Cell Line Development, Product and Application

3.7 Global Key Players of Mammalian Cell Line Development, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Mammalian Cell Line Development Breakdown Data by Type

4.1 Global Mammalian Cell Line Development Historic Market Size by Type (2019-2024)

4.2 Global Mammalian Cell Line Development Forecasted Market Size by Type (2025-2030)

5 Mammalian Cell Line Development Breakdown Data by Application

5.1 Global Mammalian Cell Line Development Historic Market Size by Application (2019-2024)

5.2 Global Mammalian Cell Line Development Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Mammalian Cell Line Development Market Size (2019-2030)

6.2 North America Mammalian Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Mammalian Cell Line Development Market Size by Country (2019-2024)

6.4 North America Mammalian Cell Line Development Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Mammalian Cell Line Development Market Size (2019-2030)

7.2 Europe Mammalian Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Mammalian Cell Line Development Market Size by Country (2019-2024)

7.4 Europe Mammalian Cell Line Development Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Mammalian Cell Line Development Market Size (2019-2030)

8.2 Asia-Pacific Mammalian Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Mammalian Cell Line Development Market Size by Region (2019-2024)

8.4 Asia-Pacific Mammalian Cell Line Development Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Mammalian Cell Line Development Market Size (2019-2030)

9.2 Latin America Mammalian Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Mammalian Cell Line Development Market Size by Country (2019-2024)

9.4 Latin America Mammalian Cell Line Development Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Mammalian Cell Line Development Market Size (2019-2030)

10.2 Middle East & Africa Mammalian Cell Line Development Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Mammalian Cell Line Development Market Size by Country (2019-2024)

10.4 Middle East & Africa Mammalian Cell Line Development Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Mammalian Cell Line Development Introduction

11.1.4 Thermo Fisher Scientific Revenue in Mammalian Cell Line Development Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 AGC Biologics

11.2.1 AGC Biologics Company Details

11.2.2 AGC Biologics Business Overview

11.2.3 AGC Biologics Mammalian Cell Line Development Introduction

11.2.4 AGC Biologics Revenue in Mammalian Cell Line Development Business (2019-2024)

11.2.5 AGC Biologics Recent Development

11.3 Sigma-Aldrich

11.3.1 Sigma-Aldrich Company Details

11.3.2 Sigma-Aldrich Business Overview

11.3.3 Sigma-Aldrich Mammalian Cell Line Development Introduction

11.3.4 Sigma-Aldrich Revenue in Mammalian Cell Line Development Business (2019-2024)

11.3.5 Sigma-Aldrich Recent Development

11.4 Fraunhofer

11.4.1 Fraunhofer Company Details

11.4.2 Fraunhofer Business Overview

11.4.3 Fraunhofer Mammalian Cell Line Development Introduction

11.4.4 Fraunhofer Revenue in Mammalian Cell Line Development Business (2019-2024)

11.4.5 Fraunhofer Recent Development

11.5 Cytena

11.5.1 Cytena Company Details

11.5.2 Cytena Business Overview

11.5.3 Cytena Mammalian Cell Line Development Introduction

11.5.4 Cytena Revenue in Mammalian Cell Line Development Business (2019-2024)

11.5.5 Cytena Recent Development

11.6 GTP Bioways

11.6.1 GTP Bioways Company Details

11.6.2 GTP Bioways Business Overview

11.6.3 GTP Bioways Mammalian Cell Line Development Introduction

11.6.4 GTP Bioways Revenue in Mammalian Cell Line Development Business (2019-2024)

11.6.5 GTP Bioways Recent Development

11.7 KBI Biopharma

11.7.1 KBI Biopharma Company Details

11.7.2 KBI Biopharma Business Overview

11.7.3 KBI Biopharma Mammalian Cell Line Development Introduction

11.7.4 KBI Biopharma Revenue in Mammalian Cell Line Development Business (2019-2024)

11.7.5 KBI Biopharma Recent Development

11.8 Lonza

11.8.1 Lonza Company Details

11.8.2 Lonza Business Overview

11.8.3 Lonza Mammalian Cell Line Development Introduction

11.8.4 Lonza Revenue in Mammalian Cell Line Development Business (2019-2024)

11.8.5 Lonza Recent Development

11.9 Abzena

11.9.1 Abzena Company Details

11.9.2 Abzena Business Overview

11.9.3 Abzena Mammalian Cell Line Development Introduction

11.9.4 Abzena Revenue in Mammalian Cell Line Development Business (2019-2024)

11.9.5 Abzena Recent Development

11.10 FUJIFILM Diosynth Biotechnologies

11.10.1 FUJIFILM Diosynth Biotechnologies Company Details

11.10.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.10.3 FUJIFILM Diosynth Biotechnologies Mammalian Cell Line Development Introduction

11.10.4 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian Cell Line Development Business (2019-2024)

11.10.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.11 Hera

11.11.1 Hera Company Details

11.11.2 Hera Business Overview

11.11.3 Hera Mammalian Cell Line Development Introduction

11.11.4 Hera Revenue in Mammalian Cell Line Development Business (2019-2024)

11.11.5 Hera Recent Development

11.12 WuXi Biologics

11.12.1 WuXi Biologics Company Details

11.12.2 WuXi Biologics Business Overview

11.12.3 WuXi Biologics Mammalian Cell Line Development Introduction

11.12.4 WuXi Biologics Revenue in Mammalian Cell Line Development Business (2019-2024)

11.12.5 WuXi Biologics Recent Development

11.13 Danaher

11.13.1 Danaher Company Details

11.13.2 Danaher Business Overview

11.13.3 Danaher Mammalian Cell Line Development Introduction

11.13.4 Danaher Revenue in Mammalian Cell Line Development Business (2019-2024)

11.13.5 Danaher Recent Development

11.14 Northway Biotech

11.14.1 Northway Biotech Company Details

11.14.2 Northway Biotech Business Overview

11.14.3 Northway Biotech Mammalian Cell Line Development Introduction

11.14.4 Northway Biotech Revenue in Mammalian Cell Line Development Business (2019-2024)

11.14.5 Northway Biotech Recent Development

11.15 Sartorius

11.15.1 Sartorius Company Details

11.15.2 Sartorius Business Overview

11.15.3 Sartorius Mammalian Cell Line Development Introduction

11.15.4 Sartorius Revenue in Mammalian Cell Line Development Business (2019-2024)

11.15.5 Sartorius Recent Development

11.16 EirGenix

11.16.1 EirGenix Company Details

11.16.2 EirGenix Business Overview

11.16.3 EirGenix Mammalian Cell Line Development Introduction

11.16.4 EirGenix Revenue in Mammalian Cell Line Development Business (2019-2024)

11.16.5 EirGenix Recent Development

11.17 Tanvex

11.17.1 Tanvex Company Details

11.17.2 Tanvex Business Overview

11.17.3 Tanvex Mammalian Cell Line Development Introduction

11.17.4 Tanvex Revenue in Mammalian Cell Line Development Business (2019-2024)

11.17.5 Tanvex Recent Development

11.18 Menarini Biotech

11.18.1 Menarini Biotech Company Details

11.18.2 Menarini Biotech Business Overview

11.18.3 Menarini Biotech Mammalian Cell Line Development Introduction

11.18.4 Menarini Biotech Revenue in Mammalian Cell Line Development Business (2019-2024)

11.18.5 Menarini Biotech Recent Development

11.19 FyoniBio

11.19.1 FyoniBio Company Details

11.19.2 FyoniBio Business Overview

11.19.3 FyoniBio Mammalian Cell Line Development Introduction

11.19.4 FyoniBio Revenue in Mammalian Cell Line Development Business (2019-2024)

11.19.5 FyoniBio Recent Development

11.20 Creative Biogene

11.20.1 Creative Biogene Company Details

11.20.2 Creative Biogene Business Overview

11.20.3 Creative Biogene Mammalian Cell Line Development Introduction

11.20.4 Creative Biogene Revenue in Mammalian Cell Line Development Business (2019-2024)

11.20.5 Creative Biogene Recent Development

11.21 Rodon Biologics

11.21.1 Rodon Biologics Company Details

11.21.2 Rodon Biologics Business Overview

11.21.3 Rodon Biologics Mammalian Cell Line Development Introduction

11.21.4 Rodon Biologics Revenue in Mammalian Cell Line Development Business (2019-2024)

11.21.5 Rodon Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

AGC Biologics

Sigma-aldrich

Fraunhofer

Cytena

GTP Bioways

KBI Biopharma

Lonza

Abzena

FUJIFILM Diosynth Biotechnologies

HERA

Wuxi Biologics

Danaher

Northway Biotech

Sartorius

EirGenix Inc.

FyoniBio GmbH

Creative Biogene

Rodon Biologics

Tanvex

Menarini Biotech

List of Tables

Table 1. Global Mammalian Cell Line Development Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CHO (Chinese Hamster Ovary) Cells

Table 3. Key Players of HEK (Human Embryonic Kidney) Cells

Table 4. Key Players of NS0 (Mouse Myeloma) Cells

Table 5. Key Players of BHK (Baby Hamster Kidney) Cells

Table 6. Key Players of Others

Table 7. Global Mammalian Cell Line Development Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Mammalian Cell Line Development Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Mammalian Cell Line Development Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Mammalian Cell Line Development Market Share by Region (2019-2024)

Table 11. Global Mammalian Cell Line Development Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Mammalian Cell Line Development Market Share by Region (2025-2030)

Table 13. Mammalian Cell Line Development Market Trends

Table 14. Mammalian Cell Line Development Market Drivers

Table 15. Mammalian Cell Line Development Market Challenges

Table 16. Mammalian Cell Line Development Market Restraints

Table 17. Global Mammalian Cell Line Development Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Mammalian Cell Line Development Market Share by Players (2019-2024)

Table 19. Global Top Mammalian Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Cell Line Development as of 2023)

Table 20. Ranking of Global Top Mammalian Cell Line Development Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Mammalian Cell Line Development Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Mammalian Cell Line Development, Headquarters and Area Served

Table 23. Global Key Players of Mammalian Cell Line Development, Product and Application

Table 24. Global Key Players of Mammalian Cell Line Development, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Mammalian Cell Line Development Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Mammalian Cell Line Development Revenue Market Share by Type (2019-2024)

Table 28. Global Mammalian Cell Line Development Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Mammalian Cell Line Development Revenue Market Share by Type (2025-2030)

Table 30. Global Mammalian Cell Line Development Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Mammalian Cell Line Development Revenue Market Share by Application (2019-2024)

Table 32. Global Mammalian Cell Line Development Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Mammalian Cell Line Development Revenue Market Share by Application (2025-2030)

Table 34. North America Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Mammalian Cell Line Development Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Mammalian Cell Line Development Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Mammalian Cell Line Development Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Mammalian Cell Line Development Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Mammalian Cell Line Development Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Mammalian Cell Line Development Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Mammalian Cell Line Development Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Mammalian Cell Line Development Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Mammalian Cell Line Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Mammalian Cell Line Development Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Mammalian Cell Line Development Market Size by Country (2025-2030) & (US$ Million)

Table 49. Thermo Fisher Scientific Company Details

Table 50. Thermo Fisher Scientific Business Overview

Table 51. Thermo Fisher Scientific Mammalian Cell Line Development Product

Table 52. Thermo Fisher Scientific Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 53. Thermo Fisher Scientific Recent Development

Table 54. AGC Biologics Company Details

Table 55. AGC Biologics Business Overview

Table 56. AGC Biologics Mammalian Cell Line Development Product

Table 57. AGC Biologics Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 58. AGC Biologics Recent Development

Table 59. Sigma-Aldrich Company Details

Table 60. Sigma-Aldrich Business Overview

Table 61. Sigma-Aldrich Mammalian Cell Line Development Product

Table 62. Sigma-Aldrich Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 63. Sigma-Aldrich Recent Development

Table 64. Fraunhofer Company Details

Table 65. Fraunhofer Business Overview

Table 66. Fraunhofer Mammalian Cell Line Development Product

Table 67. Fraunhofer Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 68. Fraunhofer Recent Development

Table 69. Cytena Company Details

Table 70. Cytena Business Overview

Table 71. Cytena Mammalian Cell Line Development Product

Table 72. Cytena Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 73. Cytena Recent Development

Table 74. GTP Bioways Company Details

Table 75. GTP Bioways Business Overview

Table 76. GTP Bioways Mammalian Cell Line Development Product

Table 77. GTP Bioways Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 78. GTP Bioways Recent Development

Table 79. KBI Biopharma Company Details

Table 80. KBI Biopharma Business Overview

Table 81. KBI Biopharma Mammalian Cell Line Development Product

Table 82. KBI Biopharma Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 83. KBI Biopharma Recent Development

Table 84. Lonza Company Details

Table 85. Lonza Business Overview

Table 86. Lonza Mammalian Cell Line Development Product

Table 87. Lonza Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 88. Lonza Recent Development

Table 89. Abzena Company Details

Table 90. Abzena Business Overview

Table 91. Abzena Mammalian Cell Line Development Product

Table 92. Abzena Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 93. Abzena Recent Development

Table 94. FUJIFILM Diosynth Biotechnologies Company Details

Table 95. FUJIFILM Diosynth Biotechnologies Business Overview

Table 96. FUJIFILM Diosynth Biotechnologies Mammalian Cell Line Development Product

Table 97. FUJIFILM Diosynth Biotechnologies Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 98. FUJIFILM Diosynth Biotechnologies Recent Development

Table 99. Hera Company Details

Table 100. Hera Business Overview

Table 101. Hera Mammalian Cell Line Development Product

Table 102. Hera Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 103. Hera Recent Development

Table 104. WuXi Biologics Company Details

Table 105. WuXi Biologics Business Overview

Table 106. WuXi Biologics Mammalian Cell Line Development Product

Table 107. WuXi Biologics Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 108. WuXi Biologics Recent Development

Table 109. Danaher Company Details

Table 110. Danaher Business Overview

Table 111. Danaher Mammalian Cell Line Development Product

Table 112. Danaher Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 113. Danaher Recent Development

Table 114. Northway Biotech Company Details

Table 115. Northway Biotech Business Overview

Table 116. Northway Biotech Mammalian Cell Line Development Product

Table 117. Northway Biotech Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 118. Northway Biotech Recent Development

Table 119. Sartorius Company Details

Table 120. Sartorius Business Overview

Table 121. Sartorius Mammalian Cell Line Development Product

Table 122. Sartorius Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 123. Sartorius Recent Development

Table 124. EirGenix Company Details

Table 125. EirGenix Business Overview

Table 126. EirGenix Mammalian Cell Line Development Product

Table 127. EirGenix Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 128. EirGenix Recent Development

Table 129. Tanvex Company Details

Table 130. Tanvex Business Overview

Table 131. Tanvex Mammalian Cell Line Development Product

Table 132. Tanvex Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 133. Tanvex Recent Development

Table 134. Menarini Biotech Company Details

Table 135. Menarini Biotech Business Overview

Table 136. Menarini Biotech Mammalian Cell Line Development Product

Table 137. Menarini Biotech Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 138. Menarini Biotech Recent Development

Table 139. FyoniBio Company Details

Table 140. FyoniBio Business Overview

Table 141. FyoniBio Mammalian Cell Line Development Product

Table 142. FyoniBio Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 143. FyoniBio Recent Development

Table 144. Creative Biogene Company Details

Table 145. Creative Biogene Business Overview

Table 146. Creative Biogene Mammalian Cell Line Development Product

Table 147. Creative Biogene Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 148. Creative Biogene Recent Development

Table 149. Rodon Biologics Company Details

Table 150. Rodon Biologics Business Overview

Table 151. Rodon Biologics Mammalian Cell Line Development Product

Table 152. Rodon Biologics Revenue in Mammalian Cell Line Development Business (2019-2024) & (US$ Million)

Table 153. Rodon Biologics Recent Development

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

Table 157. Authors List of This Report

List of Figures

Figure 1. Mammalian Cell Line Development Picture

Figure 2. Global Mammalian Cell Line Development Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Mammalian Cell Line Development Market Share by Type: 2023 VS 2030

Figure 4. CHO (Chinese Hamster Ovary) Cells Features

Figure 5. HEK (Human Embryonic Kidney) Cells Features

Figure 6. NS0 (Mouse Myeloma) Cells Features

Figure 7. BHK (Baby Hamster Kidney) Cells Features

Figure 8. Others Features

Figure 9. Global Mammalian Cell Line Development Market Size by Application (2024-2030) & (US$ Million)

Figure 10. Global Mammalian Cell Line Development Market Share by Application: 2023 VS 2030

Figure 11. Biopharmaceutical Production Case Studies

Figure 12. Drug Discovery and Development Case Studies

Figure 13. Toxicity Testing Case Studies

Figure 14. Others Case Studies

Figure 15. Mammalian Cell Line Development Report Years Considered

Figure 16. Global Mammalian Cell Line Development Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Mammalian Cell Line Development Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Mammalian Cell Line Development Market Share by Region: 2023 VS 2030

Figure 19. Global Mammalian Cell Line Development Market Share by Players in 2023

Figure 20. Global Top Mammalian Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian Cell Line Development as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Mammalian Cell Line Development Revenue in 2023

Figure 22. North America Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Mammalian Cell Line Development Market Share by Country (2019-2030)

Figure 24. United States Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Mammalian Cell Line Development Market Share by Country (2019-2030)

Figure 28. Germany Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Mammalian Cell Line Development Market Share by Region (2019-2030)

Figure 36. China Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Mammalian Cell Line Development Market Share by Country (2019-2030)

Figure 44. Mexico Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Mammalian Cell Line Development Market Share by Country (2019-2030)

Figure 48. Turkey Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. UAE Mammalian Cell Line Development Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 52. AGC Biologics Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 53. Sigma-Aldrich Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 54. Fraunhofer Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 55. Cytena Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 56. GTP Bioways Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 57. KBI Biopharma Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 58. Lonza Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 59. Abzena Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 60. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 61. Hera Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 62. WuXi Biologics Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 63. Danaher Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 64. Northway Biotech Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 65. Sartorius Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 66. EirGenix Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 67. Tanvex Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 68. Menarini Biotech Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 69. FyoniBio Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 70. Creative Biogene Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 71. Rodon Biologics Revenue Growth Rate in Mammalian Cell Line Development Business (2019-2024)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Mammalian Cell Banking Market Research Report 2025

Cell Line Development for Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Line Generation Market Research Report 2025

Global Cell Line Construction Service Market Research Report 2024

Global Stable Cell Line Development Market Insights Forecast to 2030

Mammalian Cell Culture Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mammalian Cell Expression System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mammalian Protein Expression System Market Research Report 2024

Global CRISPR Cell Line Development Market Research Report 2024

Global Chinese Hamster Ovary Cell Line Market Research Report 2024

Global CHO Cell Line Construction Service Market Research Report 2024

Global CHO Cell Line Development Service Market Research Report 2024

Global Mammalian Expression Systems Market Research Report 2025

Global Cell Culture Service Market Research Report 2025

Global Cell Line Customization Service Market Research Report 2024

Research Use Human Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Line Development Serum Market Research Report 2024

Global Mouse Cell Line Authentication Service Market Research Report 2025

Global Mammalian Cell Display Service Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions